Cenobamate for focal‐onset seizures in resistant epilepsy

Abstract

Cenobamate (Ontozry) is a new antiseizure medicine for the adjunctive treatment of focal‐onset seizures with or without secondary generalisation in patients with drug‐resistant epilepsy. This article summarises its properties and place in therapy.